Cargando…
硫利达嗪通过内质网应激介导DR5表达上调增敏TRAIL对肺癌PC9细胞的促凋亡效应
BACKGROUND AND OBJECTIVE: Tumor necrosis factor-related apoptosis-inducting ligand (TRAIL) can induce apoptosis of tumor cells, however, various of tumor cells may survive because of resistance to TRAIL-mediated apoptosis. This study is to observe the proliferation inhibition effect of TRAIL sensiti...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5972967/ https://www.ncbi.nlm.nih.gov/pubmed/28228218 http://dx.doi.org/10.3779/j.issn.1009-3419.2017.02.02 |
_version_ | 1783326508045041664 |
---|---|
collection | PubMed |
description | BACKGROUND AND OBJECTIVE: Tumor necrosis factor-related apoptosis-inducting ligand (TRAIL) can induce apoptosis of tumor cells, however, various of tumor cells may survive because of resistance to TRAIL-mediated apoptosis. This study is to observe the proliferation inhibition effect of TRAIL sensitized by thioridazine on PC9 cells through endoplasmic reticulum (ER) stress mediated up-regulation of death receptor 5 (DR5) and investigate its mechanism. METHODS: PC9 cells were treated with different concentrations of thioridazine and TRAIL alone or in combination. Cell proliferation was measured by MTT assay, and cell apoptosis and cell-surface DR5 were detected by flow cytometry. Western blotting was utilized to measure the expressions of ER stress-related proteins glucose regulated protein 78 (GRP78), C/EBP homologous protein (CHOP), p-PKR-like ER kinase (PERK), p-eukaryotic initiation factor-2α (eIF2α), activating transcription factor 4 (ATF4) and apoptosis-related proteins caspase-3, caspase-9, caspase-8, PARP, DR5. RESULTS: Thioridazine inhibited the proliferation of PC9 cells in a dose-dependent manner (P < 0.05). Thioridazine increased the inhibition and apoptosis of PC9 cells and upregulated the expression of cell-surface DR5 induced by TRAIL. Flow cytometry showed that compared with TRAIL group, combination group of TRAIL and thioridazine increased cell apoptotic rates significantly (P < 0.05). Western blotting indicated that compared with TRAIL group, expressions of Cleaved-caspase-8, Cleaved-PARP and DR5 increased significantly in combination group of TRAIL and thioridazine. The induction of DR5 and pro-apoptotic effect were mediated through activation of ER stress accompanying by increased synthesis of GRP78 and CHOP, which can be blocked by adding of ER stress inhibitor 4-PBA. CONCLUSION: Thioridazine enhanced proliferation inhibition effect of TRAIL in PC9 cells may be facilitated through ER stress mediated upregulation of DR5. |
format | Online Article Text |
id | pubmed-5972967 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | 中国肺癌杂志编辑部 |
record_format | MEDLINE/PubMed |
spelling | pubmed-59729672018-07-06 硫利达嗪通过内质网应激介导DR5表达上调增敏TRAIL对肺癌PC9细胞的促凋亡效应 Zhongguo Fei Ai Za Zhi 基础研究 BACKGROUND AND OBJECTIVE: Tumor necrosis factor-related apoptosis-inducting ligand (TRAIL) can induce apoptosis of tumor cells, however, various of tumor cells may survive because of resistance to TRAIL-mediated apoptosis. This study is to observe the proliferation inhibition effect of TRAIL sensitized by thioridazine on PC9 cells through endoplasmic reticulum (ER) stress mediated up-regulation of death receptor 5 (DR5) and investigate its mechanism. METHODS: PC9 cells were treated with different concentrations of thioridazine and TRAIL alone or in combination. Cell proliferation was measured by MTT assay, and cell apoptosis and cell-surface DR5 were detected by flow cytometry. Western blotting was utilized to measure the expressions of ER stress-related proteins glucose regulated protein 78 (GRP78), C/EBP homologous protein (CHOP), p-PKR-like ER kinase (PERK), p-eukaryotic initiation factor-2α (eIF2α), activating transcription factor 4 (ATF4) and apoptosis-related proteins caspase-3, caspase-9, caspase-8, PARP, DR5. RESULTS: Thioridazine inhibited the proliferation of PC9 cells in a dose-dependent manner (P < 0.05). Thioridazine increased the inhibition and apoptosis of PC9 cells and upregulated the expression of cell-surface DR5 induced by TRAIL. Flow cytometry showed that compared with TRAIL group, combination group of TRAIL and thioridazine increased cell apoptotic rates significantly (P < 0.05). Western blotting indicated that compared with TRAIL group, expressions of Cleaved-caspase-8, Cleaved-PARP and DR5 increased significantly in combination group of TRAIL and thioridazine. The induction of DR5 and pro-apoptotic effect were mediated through activation of ER stress accompanying by increased synthesis of GRP78 and CHOP, which can be blocked by adding of ER stress inhibitor 4-PBA. CONCLUSION: Thioridazine enhanced proliferation inhibition effect of TRAIL in PC9 cells may be facilitated through ER stress mediated upregulation of DR5. 中国肺癌杂志编辑部 2017-02-20 /pmc/articles/PMC5972967/ /pubmed/28228218 http://dx.doi.org/10.3779/j.issn.1009-3419.2017.02.02 Text en 版权所有©《中国肺癌杂志》编辑部2017 https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/ |
spellingShingle | 基础研究 硫利达嗪通过内质网应激介导DR5表达上调增敏TRAIL对肺癌PC9细胞的促凋亡效应 |
title | 硫利达嗪通过内质网应激介导DR5表达上调增敏TRAIL对肺癌PC9细胞的促凋亡效应 |
title_full | 硫利达嗪通过内质网应激介导DR5表达上调增敏TRAIL对肺癌PC9细胞的促凋亡效应 |
title_fullStr | 硫利达嗪通过内质网应激介导DR5表达上调增敏TRAIL对肺癌PC9细胞的促凋亡效应 |
title_full_unstemmed | 硫利达嗪通过内质网应激介导DR5表达上调增敏TRAIL对肺癌PC9细胞的促凋亡效应 |
title_short | 硫利达嗪通过内质网应激介导DR5表达上调增敏TRAIL对肺癌PC9细胞的促凋亡效应 |
title_sort | 硫利达嗪通过内质网应激介导dr5表达上调增敏trail对肺癌pc9细胞的促凋亡效应 |
topic | 基础研究 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5972967/ https://www.ncbi.nlm.nih.gov/pubmed/28228218 http://dx.doi.org/10.3779/j.issn.1009-3419.2017.02.02 |
work_keys_str_mv | AT liúlìdáqíntōngguònèizhìwǎngyīngjījièdǎodr5biǎodáshàngdiàozēngmǐntrailduìfèiáipc9xìbāodecùdiāowángxiàoyīng AT liúlìdáqíntōngguònèizhìwǎngyīngjījièdǎodr5biǎodáshàngdiàozēngmǐntrailduìfèiáipc9xìbāodecùdiāowángxiàoyīng AT liúlìdáqíntōngguònèizhìwǎngyīngjījièdǎodr5biǎodáshàngdiàozēngmǐntrailduìfèiáipc9xìbāodecùdiāowángxiàoyīng AT liúlìdáqíntōngguònèizhìwǎngyīngjījièdǎodr5biǎodáshàngdiàozēngmǐntrailduìfèiáipc9xìbāodecùdiāowángxiàoyīng AT liúlìdáqíntōngguònèizhìwǎngyīngjījièdǎodr5biǎodáshàngdiàozēngmǐntrailduìfèiáipc9xìbāodecùdiāowángxiàoyīng |